Earnings Feed
Start Free
Home/Filings/4/0001181158-11-000002
4//SEC Filing

MAGNUSON TERRY 4

Accession 0001181158-11-000002

CIK 0001003124other
View on SEC.govCompany Profile

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 3:42 PM ET

Size

22.0 KB

Accession

0001181158-11-000002

Insider Transaction Report

Form 4
Period: 2011-03-01
PHARMACEUTICAL PRODUCT DEVELOPMENT INCPPDI
MAGNUSON TERRY
Director
Transactions
  • Sale

    Common Stock

    2011-03-01$27.70/sh−8,281$229,384→ 16,199 total
  • Exercise/Conversion

    Common Stock

    2011-03-01$15.28/sh+8,281$126,534→ 24,480 total
  • Exercise/Conversion

    Stock Options (to buy)

    2011-03-01−8,281→ 0 total
    Exercise: $15.28From: 2001-05-15Exp: 2011-05-14→ Common Stock (8,281 underlying)
Holdings

  • Stock Options (to buy)

    Exercise: $24.26From: 2011-07-30Exp: 2020-07-30→ 9090 (9,090 underlying)
    9,090

  • Stock Options (to buy)

    Exercise: $19.19From: 2009-05-20Exp: 2019-05-20→ Common Stock (14,053 underlying)
    14,053

  • Stock Options (to buy)

    Exercise: $15.28From: 2004-05-19Exp: 2014-05-18→ Common Stock (16,561 underlying)
    16,561

  • Stock Options (to buy)

    Exercise: $32.67From: 2007-05-16Exp: 2017-05-15→ Common Stock (6,341 underlying)
    6,341

  • Stock Options (to buy)

    Exercise: $24.52From: 2010-05-20Exp: 2020-05-20→ Common Stock (10,496 underlying)
    10,496

  • Stock Options (to buy)

    Exercise: $41.32From: 2008-05-21Exp: 2018-05-20→ Common Stock (6,485 underlying)
    6,485

  • Stock Options (to buy)

    Exercise: $12.37From: 2002-05-15Exp: 2012-05-14→ Common Stock (12,421 underlying)
    12,421

  • Stock Options (to buy)

    Exercise: $13.12From: 2003-05-14Exp: 2013-05-13→ Common Stock (16,561 underlying)
    16,561

  • Stock Options (to buy)

    Exercise: $22.98From: 2005-05-18Exp: 2015-05-17→ Common Stock (5,650 underlying)
    5,650

  • Stock Options (to buy)

    Exercise: $34.18From: 2006-05-17Exp: 2016-05-16→ Common Stock (4,113 underlying)
    4,113
Footnotes (2)
  • [F1]The price shown is a weighted average; the shares were sold at prices ranging from $27.68 to $27.88. Upon request by the Commission Staff, the issuer or a security holder, full information regarding the number of shares for each separate price is available.
  • [F2]The options vest in three equal increments on 7/30/2011, 7/30/2012 and 7/30/2013.

Documents

1 file

Issuer

PHARMACEUTICAL PRODUCT DEVELOPMENT INC

CIK 0001003124

→
Entity typeother

Related Parties

1
  • filerCIK 0001181158

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 3:42 PM ET
Size
22.0 KB
View on SEC.gov